Empagliflozin improves cardiac function through the increased production of acetylcarnitine in a murine non-diabetic heart failure model

被引：0
|
作者：
Nakao, M. [1 ]
Shimizu, I. [2 ]
Yoshida, Y. [2 ]
Katsuumi, G. [1 ]
Hayashi, Y. [1 ]
Ikegami, R. [1 ]
Suda, M. [1 ]
Wakasugi, T. [1 ]
Minamino, T. [1 ]
机构：
[1] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan
[2] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol Aging & Cell Biol, Grad Sch Med & Dent, Niigata, Japan
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3496
引用
收藏
页码：2109 / 2109
页数：1
相关论文
共 50 条
  • [41] Cardiac contractility modulation improves cardiac function in a rabbit model of chronic heart failure
    Zhang, Fei-Fei
    Qi, Xiao-Yong
    Li, Ying-Xiao
    Dang, Yi
    Liu, Hui-Liang
    Yuan, Hua-Bing
    Li, Rong
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (04): : 1894 - 1899
  • [42] Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction
    Yurista, Salva R.
    Sillje, Herman H. W.
    Oberdorf-Maass, Silke U.
    Schouten, Elisabeth-Maria
    Giani, Mario G. Pavez
    Hillebrands, Jan-Luuk
    van Goor, Harry
    van Veldhuisen, Dirk J.
    de Boer, Rudolf A.
    Westenbrink, B. Daan
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (07) : 862 - 873
  • [43] Influence of spontaneous physical activity on cardiac function in murine model of heart failure
    Tyrankiewicz, U.
    Skorka, T.
    Jablonska, M.
    Osiak, A.
    Jasinski, K.
    Osip, A.
    Smeda, M.
    Zoladz, J.
    Chlopicki, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 198 - 198
  • [44] Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure
    Valiente-Alandi, Inigo
    Potter, Sarah J.
    Salvador, Ane M.
    Schafer, Allison E.
    Schips, Tobias
    Carrillo-Salinas, Francisco
    Gibson, Aaron M.
    Nieman, Michelle L.
    Perkins, Charles
    Sargent, Michelle A.
    Huo, Jiuzhou
    Lorenz, John N.
    DeFalco, Tony
    Molkentin, Jeffery D.
    Alcaide, Pilar
    Blaxall, Burns C.
    CIRCULATION, 2018, 138 (12) : 1236 - 1252
  • [45] Hirsutella sinensis fungus improves cardiac function in mouse model of heart failure
    Fang, Mingsun
    Jin, Lushuai
    Mao, Wen
    Jin, Lu
    Cai, Yueqin
    Ma, Quanxin
    Liu, Xia
    Hua, Junyi
    Zhu, Jiazhen
    Fu, Huiying
    Shou, Qiyang
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 142
  • [46] Empagliflozin Improves Right Ventricular Remodeling and Right Ventricular Systolic Function in Non-Diabetic Hfref: Insights From Porcine and Human Studies
    Santosgallego, Carlos G.
    Requena-Ibanez, Juan Antonio
    Delgado, Ariana Patricia Vargas
    Ishikawa, Kiyotake
    Sanz, Javier
    Lala, Anuradha
    Contreras, Johanna P.
    Mancini, Donna M.
    Pinney, Sean
    Bhatt, Deepak
    Fuster, Valentin
    Badimon, Juan J.
    CIRCULATION, 2023, 148
  • [47] Stress hyperglycemia: a predictor of major adverse cardiac events in non-diabetic patients with acute heart failure
    Khan, F. Fahad Raja
    Lakhta, D. R. Gul
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 110 - 111
  • [48] Stress hyperglycemia: A predictor of major adverse cardiac events in non-diabetic patients with acute heart failure
    Khan, F.
    Memon, S. A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [49] Empagliflozin reduces LV mass and improves diastolic function in an experimental model of heart failure with preserved ejection fraction
    Connelly, K.
    Zhang, Y.
    Thai, K.
    Kabir, G.
    Desjardins, J. -F.
    Gilbert, R.
    DIABETOLOGIA, 2017, 60 : S527 - S527
  • [50] Renal Denervation Improves Cardiac Function and Mitigates Pathophysiological Changes in a Novel Murine Model of Heart Failure With Preserved Ejection Fraction
    Li Zhuqing
    Lu, Chengzhi
    CIRCULATION, 2023, 148
12345